Último video

Información sobre el Cáncer de Riñón

Ver todos los videos

Artículo de la semana

  • Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors

    Recent trials have suggested predictive biomarkers in advanced clear-cell renal cell carcinoma (accRCC): International Metastatic RCC Database Consortium (IMDC) good risk or angiogenic gene signature for sunitinib and IMDC intermediate/poor risk for ipilimumab-nivolumab and T-effector cell signature or sarcomatoid dedifferentiation for atezolizumab-bevacizumab. We hypothesized that earlier described molecular subtypes, ccrcc1 to ccrcc4, could provide similar information as a single generic biomarker and molecularly characterize the heterogeneous intermediate-risk group....

Ver todos los artículos

Sobre nosotros

El L.A.R.C.G (Latin American renal Cancer Group) es un grupo de carácter científico y educativo, multicentrico, multidisciplinario e independiente. No tiene fines de lucro, y el plazo de funcionamiento es indeterminado. Esta constituido por Urólogos, Patólogos y Oncólogos, además de profesionales e investigadores relacionados al ámbito de la salud, pertenecientes a Hospitales de América Latina, España y Estados Unidos.

Leer más

Últimos Tweets

Congratulations to Dr. Gustavo Carvalhal for the excellent scientific program and the organization of the 37th Brazilian Congress of Urology. We are very grateful for the opportunity to show the development and results of LARCG. @StenioZequi

2

Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies #kidneycancer #kcsm https://t.co/KIFt0fUynE

First-line IO Combination Therapies in Metastatic Renal-cell carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium
#kidneycancer #VisualAbstract
@shaan_dudani @DrDanielHeng @drjeffreygraham @DrChoueiri

https://t.co/l232CLxcES

Load More...

Sponsor

Asociados

You don't have permission to register